Pretty sure anyone who bought after the initial profit warning would have a pretty valid case that that SRF had broken disclosure rules. Throw in the big drop prior to the halt and it starts to look very ugly.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025